Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №9 (2025) > Pregnancy course characteristics in women with a history of recurrent miscarriage due to antiphospholipid syndrome

Pregnancy course characteristics in women with a history of recurrent miscarriage due to antiphospholipid syndrome

Nart F. Kuneshko , Anton V. Ershov , Arina V. Lazarchuk , Julia E. Dobrokhotova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Aim. To evaluate the effect of the plasmapheresis procedures on the course of pregnancy in patients with recurrent miscarriage and antiphospholipid syndrome. 
Materials and methods. The study included 137 pregnant women with recurrent miscarriage due to antiphospholipid syndrome. In addition to standard therapy, 73 patients from the main group underwent a course of plasmapheresis procedures using the intermittent method at the pre-conception care stage. In the comparison group, which consisted of 64 patients, plasmapheresis was not performed. The control group included 28 women with a singleton, normal pregnancy, without an aggravated somatic medical history. 
Results. A course of plasmapheresis procedures contributed to a 59.9% reduction in the risk of spontaneous abortion due to antiphospholipid syndrome in the first trimester. In the second trimester, the risk of spontaneous miscarriage was 2.7 times lower in the main group compared to the comparison group. Also, in the main group, signs of placental insufficiency, which were detected using ultrasound, were 1.8 times less common. In the third trimester, the risk of premature birth in the comparison group was 1.9 times more common than in the main group.
Conclusion. After a course of plasmapheresis in addition to standard therapy, improved hemodynamics, a decrease in the risk of spontaneous abortion, premature birth and the incidence of placental insufficiency were demonstrated. The results of the study allow us to include plasmapheresis in the course of pre-conception care of women with antiphospholipid syndrome. 
Keywords: recurrent miscarriage, threat of spontaneous abortion, antiphospholipid syndrome, plasmapheresis, pre-conception care, placental insufficiency.

About the Author

Nart F. Kuneshko 1 , Anton V. Ershov 2 , Arina V. Lazarchuk 2 , Julia E. Dobrokhotova 3

1 Odintsovo Regional Hospital, Odintsovo Maternity Hospital, Odintsovo, Russia;

2 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;

3 Pirogov Russian National Research Medical University, Moscow, Russia

References

1. Dodig S, Čepelak I. Antiphospholipid antibodies in patients with antiphospholipid syndrome. Biochem Med (Zagreb) 2024;34(2):020504. DOI: 10.11613/BM.2024.020504 
2. Rhein AK, Rabinovich A, Abuhasira R et al. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study. Res Pract Thromb Haemost 2024;8(4):102430. DOI: 10.1016/j.rpth.2024.102430 
3. Петров Ю.А., Аридт И.Г., Бахтина А.C. Иммунологические аспекты невынашивания беременности. Главный врач Юга России. 2021;1(76):38-41. Petrov Yu.A., Aridt I.G., Baxtina A.S. Immunological aspects of miscarriage. Chief Physician of the South of Russia. 2021;1(76):38-41 (in Russian). 
4. Волков В.Г., Ахильгова З.C. Факторы ранних потерь беременности. Вестник новых медицинских технологий. 2020;(1):66-72. DOI: 10.24411/2075-4094-2020-16597 Volkov V.G., Axilgova Z.S. Early pregnancy loss factors. Bulletin of new Medical Technologies. 2020;(1):66-72. DOI: 10.24411/2075-4094-2020-16597 (in Russian). 
5. Румянцева З.С., Люманова Э.Ю., Волоцкая Н.И. и др. Предикторы неразвивающейся беременности и роль прегравидарной подготовки в профилактике повторных репродуктивных потерь. Вятский медицинский вестник. 2021;1(69):64-9. DOI: 10.24411/2220-7880-2021-10154 Rumyanceva Z.S., Lyumanova E.Yu., Voloczkaya N.I. et al. Predictors of non-developing pregnancy and the role of pre-gravidary training in the prevention of repeated reproductive losses. Vyatka Medical Bulletin. 2021;1(69):64-9. DOI: 10.24411/2220-7880-2021-10154 (in Russian). 
6. Lee EE, Jun JK, Lee EB. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy. J Korean Med Sci 2021;36(4):e24. DOI: 10.3346/jkms.2021.36.e24 
7. Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A et al. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med 2022;11(3):675. DOI: 10.3390/jcm11030675 
8. Менжинская И.В., Кашенцева М.М., Ионанидзе Т.Б. и др. Спектр антифосфолипидных антител у женщин с привычным невынашиванием беременности и их диагностическое значение. Иммунология. 2016;37(1):4-9. DOI: 10.18821/0206-4952-2016-37-1-4-9 Menzhinskaya I.V., Kashentseva M.M., Ionanidze T.B. et al. Range of antiphospholipid antibodies in women with recurrent miscarriage and their diagnostic value. Immunology. 2016;37(1):4-9. (In Russian)]. DOI: 10.18821/0206-4952-2016-37-1-4-9 (in Russian). 
9. Ahn Y, Hawkins C, Pearson E, Kubler P. Diagnosis and management of antiphospholipid syndrome. Aust Prescr 2024;47(6):179-85. DOI: 10.18773/austprescr.2024.055 
10. Bitsadze V, Khizroeva J, Lazarchuk A et al. Pediatric antiphospholipid syndrome: is it the same as an adult? J Matern Fetal Neonatal Med 2024;37(1):2390637. DOI: 10.1080/14767058.2024.2390637 
11. Mineo C, Shaul PW, Bermas BL. The pathogenesis of obstetric APS: a 2023 update. Clin Immunol 2023;255:109745. DOI: 10.1016/j.clim. 2023.109745 
12. Чермных С.В. Синдром эндогенной интоксикации в акушерстве. Часть 4. Лечебный плазмаферез (клиническая лекция). Медико-социальные проблемы семьи. 2019;24(1):87-97. Chermnyx S.V. Endogenous intoxication syndrome in obstetrics. Part 4. Therapeutic plasmapheresis (clinical lecture). Medical and social problems of the family. 2019; 24(1):87-97 (in Russian). 
13. Hoxha A, Favaro M, Calligaro A et al. Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study. Thromb Haemost 2020;120(1):36-43. DOI: 10.1055/s-0039-1697665 
14. Arreola-Diaz R, Majluf-Cruz A, Sanchez-Torres LE et al. The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System. Clin Appl Thromb Hemost 2022;28:10760296221088576. DOI: 10.1177/10760296221088576 
15. Misasi R, Longo A, Recalchi S et al. Molecular Mechanisms of “Antiphospholipid Antibodies” and Their Paradoxical Role in the Pathogenesis of Seronegative APS. Int J Mol Sci 2020;21:8411. DOI: 10.3390/ijms21218411 
16. Cohen H, Cuadrado MJ, Erkan D et al. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus 2020;29(12):1571-93. DOI: 10.1177/0961203320950461 
17. Urban ML, Bettiol A, Mattioli I et al. Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis. Intern Emerg Med 2021;16(5):1357-67. DOI: 10.1007/s11739-020-02609-4 
18. D'Ippolito S, Barbaro G, Paciullo C et al. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms. Int J Mol Sci 2023;24(4):3195. DOI: 10.3390/ijms24043195 
19. Комилжанова Д.К. Роль антифосфолипидного синдрома в профилактике невынашивания беременности. Биология и интегративная медицина. 2017;(5):21-7. Komilzhanova D.K. Role of antiphospholipid syndrome in preventing miscarriage. Biology and integrative medicine. 2017;(5):21-7 (in Russian). 
20. Демина ТН. Тактика ведения беременности и родов у беременных с комбинированной формой тромбофилии. Медико-социальные проблемы семьи. 2019;24(2):14-21. Demina T.N. Pregnancy and delivery management tactics in pregnant women with a combined form of thrombophilia. Medical and social problems of the family. 2019;24(2):14-21 (in Russian).

For citation: Kuneshko N.F., Ershov A.V., Lazarchuk A.V., Dobrokhotova J.E. Pregnancy course characteristics in women with a history of recurrent miscarriage due to antiphospholipid syndrome. Clinical review for general practice. 2025; 6 (9): 63–67 (In Russ.). DOI: 10.47407/kr2025.6.9.00674


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru